Zobrazeno 1 - 10
of 243
pro vyhledávání: '"Kleinovink JW"'
Autor:
Kleinovink JW; Department of Immunology, Tumor Immunology Group, Leiden University Medical Center, Leiden, The Netherlands., Ossendorp F; Department of Immunology, Tumor Immunology Group, Leiden University Medical Center, Leiden, The Netherlands. f.a.ossendorp@lumc.nl.
Publikováno v:
Methods in molecular biology (Clifton, N.J.) [Methods Mol Biol] 2022; Vol. 2451, pp. 579-588.
Autor:
Kleinovink JW; Department of Immunology, Tumor Immunology group, Leiden University Medical Center, Leiden, The Netherlands., Ossendorp F; Department of Immunology, Tumor Immunology group, Leiden University Medical Center, Leiden, The Netherlands. F.A.OSSENDORP@LUMC.NL.
Publikováno v:
Methods in molecular biology (Clifton, N.J.) [Methods Mol Biol] 2022; Vol. 2451, pp. 589-596.
Autor:
Kleinovink JW; Department of Immunology, Tumor Immunology Group, Leiden University Medical Center, Leiden, The Netherlands., Ossendorp F; Department of Immunology, Tumor Immunology Group, Leiden University Medical Center, Leiden, The Netherlands. F.A.OSSENDORP@LUMC.NL.
Publikováno v:
Methods in molecular biology (Clifton, N.J.) [Methods Mol Biol] 2022; Vol. 2451, pp. 597-604.
Autor:
Beyranvand Nejad E; Medical Oncology, Oncode institute, Leiden University Medical Center, Leiden, Zuid-Holland, The Netherlands., Labrie C; Medical Oncology, Oncode institute, Leiden University Medical Center, Leiden, Zuid-Holland, The Netherlands., van Elsas MJ; Medical Oncology, Oncode institute, Leiden University Medical Center, Leiden, Zuid-Holland, The Netherlands., Kleinovink JW; Medical Oncology, Oncode institute, Leiden University Medical Center, Leiden, Zuid-Holland, The Netherlands., Mittrücker HW; Department of Immunology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Franken KLMC; Department of Immunology, Leiden University Medical Center, Leiden, Zuid-Holland, The Netherlands., Heink S; Experimental Neuroimmunology, Technische Universität München, Munchen, Bayern, Germany., Korn T; Experimental Neuroimmunology, Technische Universität München, Munchen, Bayern, Germany., Arens R; Department of Immunology, Leiden University Medical Center, Leiden, Zuid-Holland, The Netherlands., van Hall T; Medical Oncology, Oncode institute, Leiden University Medical Center, Leiden, Zuid-Holland, The Netherlands., van der Burg SH; Medical Oncology, Oncode institute, Leiden University Medical Center, Leiden, Zuid-Holland, The Netherlands shvdburg@lumc.nl.
Publikováno v:
Journal for immunotherapy of cancer [J Immunother Cancer] 2021 Apr; Vol. 9 (4).
Autor:
Um‐e‐Kalsoom1 (AUTHOR), Wang, Shiqi1 (AUTHOR), Qu, Junle1 (AUTHOR), Liu, Liwei1 (AUTHOR) liulw@szu.edu.cn
Publikováno v:
Cancer Medicine. Oct2024, Vol. 13 Issue 19, p1-31. 31p.
Autor:
Beyranvand Nejad E; Oncode institute, Medical Oncology, Leiden University Medical Center, Leiden, The Netherlands., Labrie C; Oncode institute, Medical Oncology, Leiden University Medical Center, Leiden, The Netherlands., Abdulrahman Z; Oncode institute, Medical Oncology, Leiden University Medical Center, Leiden, The Netherlands., van Elsas MJ; Oncode institute, Medical Oncology, Leiden University Medical Center, Leiden, The Netherlands., Rademaker E; Pathology, Leiden University Medical Center, Leiden, The Netherlands., Kleinovink JW; Oncode institute, Medical Oncology, Leiden University Medical Center, Leiden, The Netherlands., van der Sluis TC; Immunohematology and Bloodtransfusion, Leiden Universitair Medisch Centrum, Leiden, The Netherlands., van Duikeren S; Immunohematology and Bloodtransfusion, Leiden Universitair Medisch Centrum, Leiden, The Netherlands., Teunisse AFAS; Cell and Chemical Biology, Leiden University Medical Center, Leiden, The Netherlands., Jochemsen AG; Cell and Chemical Biology, Leiden University Medical Center, Leiden, The Netherlands., Oosting J; Pathology, Leiden University Medical Center, Leiden, The Netherlands., de Miranda NFCC; Pathology, Leiden University Medical Center, Leiden, The Netherlands., Van Hall T; Oncode institute, Medical Oncology, Leiden University Medical Center, Leiden, The Netherlands., Arens R; Immunohematology and Bloodtransfusion, Leiden Universitair Medisch Centrum, Leiden, The Netherlands., van der Burg SH; Oncode institute, Medical Oncology, Leiden University Medical Center, Leiden, The Netherlands shvdburg@lumc.nl.
Publikováno v:
Journal for immunotherapy of cancer [J Immunother Cancer] 2020 Sep; Vol. 8 (2).
Autor:
van Elsas M; Medical Oncology, Oncode institute, Leiden University Medical Center, Leiden, The Netherlands., Kleinovink JW; Medical Oncology, Oncode institute, Leiden University Medical Center, Leiden, The Netherlands., Moerland M; Centre for Human Drug Research, Leiden, The Netherlands., Feiss G; Cutanea Life Sciences, Wayne, Pennsylvania, USA., Beyrend G; Immunohematology and Blood Transfusion, Leiden University Medical Center, Leiden, The Netherlands., Arens R; Immunohematology and Blood Transfusion, Leiden University Medical Center, Leiden, The Netherlands., Mei H; Sequencing Analysis Support Core, Leiden University Medical Center, Leiden, The Netherlands., Nibbering PH; Infectious Diseases, Leiden University Medical Center, Leiden, The Netherlands., Jirka SM; Centre for Human Drug Research, Leiden, The Netherlands., van Hall T; Medical Oncology, Oncode institute, Leiden University Medical Center, Leiden, The Netherlands., van der Burg SH; Medical Oncology, Oncode institute, Leiden University Medical Center, Leiden, The Netherlands shvdburg@lumc.nl.
Publikováno v:
Journal for immunotherapy of cancer [J Immunother Cancer] 2020 Sep; Vol. 8 (2).
Autor:
Huis In 't Veld RV; Department of Radiology, Leiden University Medical Centre (LUMC), the Netherlands., Ritsma L; Department of Cell and Chemical Biology, LUMC, Leiden, the Netherlands., Kleinovink JW; Department of Medical Oncology, LUMC, Leiden, the Netherlands., Que I; Department of Radiology, Leiden University Medical Centre (LUMC), the Netherlands., Ossendorp F; Department of Immunohematology and Blood Transfusion, LUMC, Leiden, the Netherlands., Cruz LJ; Department of Radiology, Leiden University Medical Centre (LUMC), the Netherlands. Electronic address: l.j.cruz_ricondo@lumc.nl.
Publikováno v:
Journal of controlled release : official journal of the Controlled Release Society [J Control Release] 2020 Apr 10; Vol. 320, pp. 19-31. Date of Electronic Publication: 2019 Dec 31.
Autor:
Kleinovink JW; Department of Immunohematology and Blood Transfusion, Tumor Immunology, Leiden University Medical Center, Leiden, Netherlands., Mezzanotte L; Department of Radiology and Nuclear Medicine, Optical Molecular Imaging, Erasmus Medical Center, Rotterdam, Netherlands.; Department of Molecular Genetics, Erasmus Medical Center Rotterdam, Netherlands., Zambito G; Department of Radiology and Nuclear Medicine, Optical Molecular Imaging, Erasmus Medical Center, Rotterdam, Netherlands.; Department of Molecular Genetics, Erasmus Medical Center Rotterdam, Netherlands.; Medres, Cologne, Germany., Fransen MF; Department of Immunohematology and Blood Transfusion, Tumor Immunology, Leiden University Medical Center, Leiden, Netherlands., Cruz LJ; Translational Nanobiomaterials and Imaging, Department of Radiology, Leiden University Medical Center, Leiden, Netherlands., Verbeek JS; Department of Human Genetics, Leiden University Medical Center, Leiden, Netherlands., Chan A; Percuros B.V., Enschede, Netherlands., Ossendorp F; Department of Immunohematology and Blood Transfusion, Tumor Immunology, Leiden University Medical Center, Leiden, Netherlands., Löwik C; Department of Radiology and Nuclear Medicine, Optical Molecular Imaging, Erasmus Medical Center, Rotterdam, Netherlands.; Department of Molecular Genetics, Erasmus Medical Center Rotterdam, Netherlands.; Department of Oncology, CHUV Lausanne University Hospital, Lausanne, Switzerland.
Publikováno v:
Frontiers in immunology [Front Immunol] 2019 Jan 08; Vol. 9, pp. 3097. Date of Electronic Publication: 2019 Jan 08 (Print Publication: 2018).
Autor:
Zom GG; Department of Immunohematology and Blood Transfusion, section Tumorimmunology, Leiden University Medical Center, Leiden, The Netherlands., Willems MMJHP; Leiden Institute of Chemistry, Leiden University, Leiden, The Netherlands., Khan S; Department of Immunohematology and Blood Transfusion, section Tumorimmunology, Leiden University Medical Center, Leiden, The Netherlands., van der Sluis TC; Department of Immunohematology and Blood Transfusion, section Tumorimmunology, Leiden University Medical Center, Leiden, The Netherlands., Kleinovink JW; Department of Immunohematology and Blood Transfusion, section Tumorimmunology, Leiden University Medical Center, Leiden, The Netherlands., Camps MGM; Department of Immunohematology and Blood Transfusion, section Tumorimmunology, Leiden University Medical Center, Leiden, The Netherlands., van der Marel GA; Leiden Institute of Chemistry, Leiden University, Leiden, The Netherlands., Filippov DV; Leiden Institute of Chemistry, Leiden University, Leiden, The Netherlands., Melief CJM; Department of Immunohematology and Blood Transfusion, section Tumorimmunology, Leiden University Medical Center, Leiden, The Netherlands.; ISA Pharmaceuticals BV, Leiden, The Netherlands., Ossendorp F; Department of Immunohematology and Blood Transfusion, section Tumorimmunology, Leiden University Medical Center, Leiden, The Netherlands. f.a.ossendorp@lumc.nl.
Publikováno v:
Journal for immunotherapy of cancer [J Immunother Cancer] 2018 Dec 12; Vol. 6 (1), pp. 146. Date of Electronic Publication: 2018 Dec 12.